Lixte Biotechnology Holdings Stock Price Prediction
| LIXTW Stock | USD 0.03 0 21.30% |
Oversold Vs Overbought
36
Oversold | Overbought |
Using Lixte Biotechnology hype-based prediction, you can estimate the value of Lixte Biotechnology Holdings from the perspective of Lixte Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lixte Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Lixte because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lixte Biotechnology after-hype prediction price | USD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lixte |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lixte Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lixte Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Lixte Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lixte Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lixte Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lixte Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Lixte Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lixte Biotechnology's historical news coverage. Lixte Biotechnology's after-hype downside and upside margins for the prediction period are 0.00 and 17.38, respectively. We have considered Lixte Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lixte Biotechnology is out of control at this time. Analysis and calculation of next after-hype price of Lixte Biotechnology is based on 3 months time horizon.
Lixte Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lixte Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lixte Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lixte Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.79 | 17.22 | 0.00 | 0.01 | 1 Events / Month | 0 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 7.53 |
|
Lixte Biotechnology Hype Timeline
Lixte Biotechnology is now traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Lixte is anticipated to increase in value after the next headline, with the price projected to jump to 0.03 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 7.53%, whereas the daily expected return is now at 0.79%. The volatility of related hype on Lixte Biotechnology is about 218527.92%, with the expected price after the next announcement by competition of 0.02. Assuming the 90 days horizon the next anticipated press release will be very soon. Check out Lixte Biotechnology Basic Forecasting Models to cross-verify your projections.Lixte Biotechnology Related Hype Analysis
Having access to credible news sources related to Lixte Biotechnology's direct competition is more important than ever and may enhance your ability to predict Lixte Biotechnology's future price movements. Getting to know how Lixte Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lixte Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ENTXW | Entera Bio | 0.0008 | 2 per month | 30.23 | 0.12 | 135.48 | (57.53) | 266.82 | |
| ARTLW | Artelo Biosciences | 0.00 | 0 per month | 23.45 | 0.08 | 68.38 | (41.25) | 147.53 | |
| RVPHW | Reviva Pharmaceuticals Holdings | (0.04) | 3 per month | 15.14 | 0.16 | 28.57 | (22.22) | 129.53 | |
| BCDAW | BioCardia | (0.0002) | 1 per month | 18.27 | 0.06 | 57.25 | (40.00) | 139.50 | |
| ATNFW | CannBioRx Life Sciences | 0.00 | 0 per month | 10.29 | 0.09 | 29.23 | (17.35) | 133.59 |
Lixte Biotechnology Additional Predictive Modules
Most predictive techniques to examine Lixte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lixte using various technical indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lixte Biotechnology Predictive Indicators
The successful prediction of Lixte Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lixte Biotechnology Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lixte Biotechnology based on analysis of Lixte Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lixte Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lixte Biotechnology's related companies. | 2010 | 2023 | 2024 (projected) | Dividend Yield | 8.56E-4 | 0.001613 | 0.001059 | Price To Sales Ratio | 11.69 | 10.52 | 9.35 |
Story Coverage note for Lixte Biotechnology
The number of cover stories for Lixte Biotechnology depends on current market conditions and Lixte Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lixte Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lixte Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lixte Biotechnology Short Properties
Lixte Biotechnology's future price predictability will typically decrease when Lixte Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lixte Biotechnology Holdings often depends not only on the future outlook of the potential Lixte Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lixte Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 4.2 M |
Additional Tools for Lixte Stock Analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.